Sarcopenia-specific interventions
1 paper2 findings
- 1 lab in 1 country
- 1 finding against
Outcomes
1IGF-1
no changein humans1upin humans1
1 study
IGF-1
no changein humans1upin humans1
Sarcopenia-specific interventions have no effect on IGF-1 in humans.
“However, this change was not significant when analyses were restricted to RCTs reporting significant improvement in key sarcopenia measures.”
Reviewanalysis restricted to RCTs reporting significant improvement in key sarcopenia measuresblood
Aging cell12 Jan 2026
Sarcopenia-specific interventions increase IGF-1 in humans (SMD 0.46, 95% CI 0.04–0.88).
“Among non-muscle-specific BBMs, IGF-1 was significantly impacted by the studied interventions (SMD = 0.46, CI = [0.04; 0.88]).”
Reviewsarcopeniablood
Aging cell12 Jan 2026
Latest
1 in 12 monthsAging Cell
Frequently Reported Blood Biomarkers in Sarcopenia Clinical Trials: A Systematic Review and Meta-Analysis
Meta-analysis of randomised trialsSarcopenia